While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...

Bayer receives UK MHRA approval for Lynkuet to treat moderate to severe vasomotor symptoms associated with menopause: Berlin Saturday, July 12, 2025, 10:00 Hrs [IST] Bayer announc ...

Women in the UK will soon have access to a new daily pill designed to alleviate hot flushes during menopause, following its ...

A treatment for menopausal hot flushes has been approved by medicine watchdogs. UK regulators have become the first in the ...

Biocon Biologics Ltd received UK approval for Vevzuo and Evfraxy, biosimilars of Denosumab. Vevzuo is approved for ...

Millions of lives and decades of progress hang in the balance,” says the president of the International AIDS Society (IAS) ...

Women will be able to access a daily pill for hot flushes during menopause after it was given the green light for UK use. The Medicines and Healthcare products Regulatory Agency (MHRA) said it is the ...

The US biosimilar market expands with new denosumab options, enhancing treatment for patients with osteoporosis and ...

NBA free agency 2025: Live updates, news, rumors as Moe Wagner re-signs with Magic, Deandre Ayton reportedly agrees to terms with the Los Angeles Lakers Videos cannot play due to a network issue.

The WSJ/College Pulse 2025 Best Colleges in the U.S. ranking was developed and executed in collaboration with our research partners College Pulse and Statista. The ranking scores colleges based on ...